Table 1.
Baseline Characteristics of Included Patients
| Variables | All Patients | VBCA Group | PBCA Group | P value | |||
|---|---|---|---|---|---|---|---|
| No.Pts (n) | Mean ± SD or Frequency (Percentage) | No.Pts (n) | Mean ± SD or Median (Range) or Frequency (Percentage) | No.Pts (n) | Mean ± SD or Frequency (Percentage) | ||
| Age (years) | 65 | 48.9±13.4 | 17 | 45.8±11.6 | 48 | 49.7±13.8 | 0.399 |
| Gender (male) | 65 | 32 (50.8) | 17 | 9 (52.9) | 48 | 24 (50.0) | 0.835 |
| BMI (kg/m2) | 64 | 23.8±4.3 | 16 | 22.6 (20.6–30.9) | 48 | 24.1±3.0 | 0.659 |
| Current smoking | 64 | 12 (19.4) | 16 | 3 (18.8) | 48 | 9 (18.8) | 1.000 |
| Current alcohol use | 64 | 7 (11.3) | 16 | 1 (6.3) | 48 | 6 (12.5) | 0.817 |
Abbreviations: VBCA, a combination of vonoprazan, bismuth, clarithromycin, and amoxicillin; PBCA, a combination of pantoprazole, bismuth, clarithromycin, and amoxicillin.